Inactive Instrument

News Cannabics Pharmaceuticals Inc. Other OTC

Equities

CNBX

US13764M1009

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	Apr. 16	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	Jan. 12	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	Nov. 30	CI
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-07-14	CI
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	23-06-05	AQ
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	23-06-02	AQ
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-04-14	AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-04-14	CI
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	23-02-08	AQ
CNBX Pharmaceuticals Inc. Announces Board Resignations	23-02-08	CI
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-01-13	AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23-01-13	CI
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	22-12-29	AQ
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	22-12-29	CI
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-11-30	AQ
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	22-11-30	CI
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	22-11-29	CI
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	22-11-08	PR
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	22-11-07	CI
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	22-10-18	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cannabics Pharmaceuticals Inc. Other OTC

Equities

CNBX

US13764M1009

Summary

Filters